Edition:
United States

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

1.57USD
10:38am EDT
Change (% chg)

$0.03 (+1.95%)
Prev Close
$1.54
Open
$1.56
Day's High
$1.57
Day's Low
$1.56
Volume
19,620
Avg. Vol
45,885
52-wk High
$2.58
52-wk Low
$0.97

Latest Key Developments (Source: Significant Developments)

Second Sight Appoints John Blake Chief Financial Officer
Thursday, 22 Mar 2018 08:00am EDT 

March 22 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT APPOINTS JOHN T. BLAKE CHIEF FINANCIAL OFFICER.SECOND SIGHT MEDICAL PRODUCTS INC - BLAKE SUCCEEDS THOMAS MILLER AS CFO.  Full Article

Second Sight Appoints Gregg Williams As Chairman Of The Board Of Directors
Friday, 16 Mar 2018 08:00am EDT 

March 16 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT APPOINTS GREGG WILLIAMS AS CHAIRMAN OF THE BOARD OF DIRECTORS.SECOND SIGHT APPOINTS GREGG WILLIAMS AS CHAIRMAN OF THE BOARD OF DIRECTORS.SECOND SIGHT MEDICAL PRODUCTS INC - ‍ GREGG WILLIAMS SUCCEEDS ROBERT GREENBERG.SECOND SIGHT MEDICAL PRODUCTS INC - ‍ ROBERT GREENBERG REMAINS A MEMBER OF BOARD​.  Full Article

Second Sight Q4 Loss Per Share $0.13
Wednesday, 7 Mar 2018 04:05pm EST 

March 7 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.13.Q4 SALES $3.1 MILLION VERSUS $715,000.Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.14 EXCLUDING ITEMS.  Full Article

SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION SYSTEM
Wednesday, 8 Nov 2017 09:48am EST 

Nov 8 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE ORION CORTICAL VISUAL PROSTHESIS SYSTEM.ORION ALLOWS PATIENTS MORE TIMELY ACCESS TO MEDICAL DEVICES BY EXPEDITING DEVELOPMENT, ASSESSMENT, REVIEW .FDA HAS GRANTED EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION CORTICAL VISUAL PROSTHESIS SYSTEM​.  Full Article

Second Sight Medical Products reports Q3 loss per share $0.12
Thursday, 2 Nov 2017 04:00pm EDT 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second sight reports third quarter 2017 financial results.Q3 loss per share $0.12.Q3 sales $1.6 million versus $1.2 million.Second Sight Medical Products Inc - qtrly adjusted loss per share $0.11.  Full Article

Second Sight receives FDA approval to begin first Orion human clinical study
Thursday, 2 Nov 2017 08:05am EDT 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second Sight receives full FDA approval to begin first Orion human clinical study.Second sight-‍completed additional device testing, addressed remaining questions requested by FDA in prior conditional approval announced on Aug 28.Second Sight Medical Products Inc - ‍approval for Orion human clinical study allows two U.S. Sites to enroll up to five total patients​.  Full Article

Second Sight Medical Products files for mixed shelf of upto $100 mln‍​
Tuesday, 31 Oct 2017 06:16am EDT 

Oct 31 (Reuters) - Second Sight Medical Products Inc :Second Sight Medical Products Inc files for mixed shelf of upto $100 million - sec filing‍​.  Full Article

Second Sight receives conditional FDA approval to begin first Orion human clinical study
Monday, 28 Aug 2017 08:00am EDT 

Aug 28 (Reuters) - Second Sight Medical Products Inc :Second sight receives conditional FDA approval to begin first Orion human clinical study.Second sight medical products inc- ‍fda has also requested that company conduct additional device testing and address outstanding questions​.  Full Article

Second Sight Medical Products Q2 sales $2.2 mln
Tuesday, 1 Aug 2017 04:01pm EDT 

Aug 1 (Reuters) - Second Sight Medical Products Inc :Second Sight reports second quarter 2017 financial results.Q2 adjusted non-GAAP loss per share $0.12 excluding items.Q2 sales $2.2 million versus $1.0 million.Says total revenue was $2.2 million for q2 of 2017, compared with $1.0 million in q2 of 2016.  Full Article

Second Sight says Argus implant is available in Russia
Wednesday, 26 Jul 2017 08:30am EDT 

July 26 (Reuters) - Second Sight Medical Products Inc :Second sight announces market entry into russia with first implant of argus ii retinal prosthesis system.Second sight medical products inc - implant was facilitated by country's exclusive distribution partner, medical equipment trading company.  Full Article

BRIEF-Second Sight Reports Q1 Loss Per Share $0.17

* Q1 NON-GAAP LOSS PER SHARE $0.14 EXCLUDING ITEMS Source text for Eikon: Further company coverage: